Molecular Partners AG ADR (MOLN) — Cash Flow Reinvestment Rate
Molecular Partners AG ADR (MOLN) has a Cash Flow Reinvestment Rate of 0.57x as of March 2022, reinvesting $93.61 Million (capex $380.00K plus investments $-93.23 Million) from operating cash flow of $163.56 Million. Explore Molecular Partners AG ADR capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Molecular Partners AG ADR Cash Flow Reinvestment Rate (2015–2022)
Historical reinvestment intensity for Molecular Partners AG ADR across 2 annual periods. Also explore total assets of Molecular Partners AG ADR for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Molecular Partners AG ADR (2015–2022)
Year-by-year capital reinvestment analysis for Molecular Partners AG ADR. For live market cap and broader valuation context, see Molecular Partners AG ADR stock valuation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.86x | $102.54 Million | $118.57 Million | $1.42 Million | ▲ +1551.2% |
| 2015 | 0.05x | $1.39 Million | $26.50 Million | $1.39 Million | — |